Matinas BioPharma | Investor Presentation Deck | 29 slides · page 25 of 29
Includes study design details (n=55, female C57BL/6 mice) and statistical significance markers for treatment groups.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 3/3 list 1/1 title 1/1
Components 5
bar-vertical bar-vertical line bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.